Is it possible to increase pCR in the neoadjuvant treatment with a dose-dense/sequential combination?: results from a phase II Trial combining epirubicin and cyclophosphamide followed by paclitaxel and gemcitabine ± trastuzumab in stage II and III b (Q43232555)
Jump to navigation
Jump to search
scientific article published in October 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Is it possible to increase pCR in the neoadjuvant treatment with a dose-dense/sequential combination?: results from a phase II Trial combining epirubicin and cyclophosphamide followed by paclitaxel and gemcitabine ± trastuzumab in stage II and III b |
scientific article published in October 2010 |
Statements
1 reference
Is it possible to increase pCR in the neoadjuvant treatment with a dose-dense/sequential combination?: results from a phase II Trial combining epirubicin and cyclophosphamide followed by paclitaxel and gemcitabine ± trastuzumab in stage II and III b (English)
1 reference
Alfonso Sánchez-Muñoz
1 reference
R Dueñas-García
1 reference
A Jaén-Morago
1 reference
E Carrasco
1 reference
I Chacón
1 reference
A M García-Tapiador
1 reference
A L Ortega-Granados
1 reference
E Martínez-Ortega
1 reference
N Ribelles
1 reference
M Fernández-Navarro
1 reference
C de la Torre-Cabrera
1 reference
B Dueñas
1 reference
A I Rueda
1 reference
J Martínez
1 reference
C Ramírez Tortosa
1 reference
M D Martín-Salvago
1 reference
P Sánchez-Rovira
1 reference
1 October 2010
1 reference
1 reference
Identifiers
1 reference